1-3 of 3
Emily M McWilliams, PhD
Close
Sort by
Journal Articles

Mass Cytometry Identifies T Cell Populations Associated with Severe Hepatotoxicity in CLL Patients on Upfront Idelalisib

Alexander R. Vartanov, MD, Tiago R Matos, MD, Emily M. McWilliams, PhD, Deepti Gadi, PhD, Deepak Rao, MD PhD, Siddha Kasar, PhD, Benjamin L. Lampson, MD PhD, Stacey M. Fernandes, BS, Jerome Ritz, MD PhD, Jennifer R. Brown, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4413.
https://doi.org/10.1182/blood-2018-99-118734
Published: 2018
Journal Articles

Activating MAPK Pathway Mutations Mediate Primary Resistance to PI3K Inhibitors in Chronic Lymphocytic Leukemia (CLL)

Ishwarya Murali, PhD BS, Siddha Kasar, PhD, Emily M. McWilliams, PhD, Gilad Itchaki, Svitlana Tyekucheva, PhD, Dimitri Livitz, BS, Ignaty Leshchiner, PhD, Shuai Dong, PhD, Stacey M. Fernandes, BS, Gad Getz, PhD, Amy J. Johnson, PhD, Jennifer R. Brown, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 587.
https://doi.org/10.1182/blood-2018-99-115304
Published: 2018
Journal Articles

Rare Germline Variant in NFATC4 Associated with Familial Chronic Lymphocytic Leukemia

Gilad Itchaki, Grace Tiao, PhD, Ma Reina D. Improgo, PhD, Siddha Kasar, PhD, Bethany Tesar, MS, Stacey Marie Fernandes, BS, Nathalie Pochet, PhD, Emily M McWilliams, PhD, Harrison Bai, Arnold S. Freedman, MD, Gad Getz, PhD, Jennifer R. Brown, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2993.
https://doi.org/10.1182/blood.V130.Suppl_1.2993.2993
Published: 2017